96 related articles for article (PubMed ID: 8712701)
1. Effects of glycosylated and non-glycosylated G-CSFs, alone and in combination with other cytokines, on the growth of human progenitor cells.
Pedrazzoli P; Gibelli N; Pavesi L; Preti P; Piolini M; Bertolini F; Robustelli della Cuna G
Anticancer Res; 1996; 16(4A):1781-5. PubMed ID: 8712701
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
3. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant cytokines on colony formation by irradiated human cord blood CD34+ hematopoietic progenitor cells.
Goff JP; Shields DS; Boggs SS; Greenberger JS
Radiat Res; 1997 Jan; 147(1):61-9. PubMed ID: 8989371
[TBL] [Abstract][Full Text] [Related]
5. Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells.
Shapiro F; Yao TJ; Moskowitz C; Reich L; Wuest DL; Heimfeld S; McNiece IK; Gabrilove J; Nimer S; Moore MA
Clin Cancer Res; 1997 Sep; 3(9):1571-8. PubMed ID: 9815845
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation of recombinant human granulocyte colony stimulating factor: implications for stability and potency.
Nissen C
Eur J Cancer; 1994; 30A Suppl 3():S12-4. PubMed ID: 7535065
[TBL] [Abstract][Full Text] [Related]
7. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
Haas R; Murea S
Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
[TBL] [Abstract][Full Text] [Related]
8. Effect of glycosylation of recombinant human granulocytic colony-stimulating factor on expansion cultures of umbilical cord blood CD34+ cells.
Querol S; Cancelas JA; Amat L; Capmany G; Garcia J
Haematologica; 1999 Jun; 84(6):493-8. PubMed ID: 10366791
[TBL] [Abstract][Full Text] [Related]
9. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
[TBL] [Abstract][Full Text] [Related]
10. Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.
Shields LE; Kiem HP; Andrews RG
Am J Obstet Gynecol; 2000 Sep; 183(3):732-7. PubMed ID: 10992201
[TBL] [Abstract][Full Text] [Related]
11. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines.
Muszynski KW; Ruscetti FW; Gooya JM; Linnekin DM; Keller JR
Stem Cells; 1997; 15(1):63-72. PubMed ID: 9007224
[TBL] [Abstract][Full Text] [Related]
12. Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages.
LaIuppa JA; Papoutsakis ET; Miller WM
Exp Hematol; 1998 Aug; 26(9):835-43. PubMed ID: 9694504
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF.
Höglund M; Smedmyr B; Simonsson B; Tötterman T; Bengtsson M
Bone Marrow Transplant; 1996 Jul; 18(1):19-27. PubMed ID: 8831991
[TBL] [Abstract][Full Text] [Related]
14. Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor.
Carulli G; Mattii L; Azzarà A; Brizzi S; Galimberti S; Zucca A; Benedetti E; Petrini M
Am J Hematol; 2006 May; 81(5):318-23. PubMed ID: 16628714
[TBL] [Abstract][Full Text] [Related]
15. Expansion of human umbilical cord blood CD34+ hematopoietic progenitor cells with recombinant growth factors.
Akabutu JJ; Chan JR
Prog Clin Biol Res; 1994; 389():399-404. PubMed ID: 7535448
[No Abstract] [Full Text] [Related]
16. Granulocyte-colony stimulating factor and stem cell factor are the crucial factors in long-term culture of human primitive hematopoietic cells supported by a murine stromal cell line.
Nishi N; Ishikawa R; Inoue H; Nishikawa M; Kakeda M; Yoneya T; Tsumura H; Ohashi H; Yamaguchi Y; Motoki K; Sudo T; Mori KJ
Exp Hematol; 1996 Sep; 24(11):1312-21. PubMed ID: 8862442
[TBL] [Abstract][Full Text] [Related]
17. Superior mobilisation of haematopoietic progenitor cells with glycosylated G-CSF in male but not female unrelated stem cell donors.
Fischer JC; Frick M; Wassmuth R; Platz A; Punzel M; Wernet P
Br J Haematol; 2005 Sep; 130(5):740-6. PubMed ID: 16115131
[TBL] [Abstract][Full Text] [Related]
18. Preclinical ex vivo expansion of G-CSF-mobilized peripheral blood stem cells: effects of serum-free media, cytokine combinations and chemotherapy.
Li K; Li CK; Chuen CK; Tsang KS; Fok TF; James AE; Lee SM; Shing MM; Chik KW; Yuen PM
Eur J Haematol; 2005 Feb; 74(2):128-35. PubMed ID: 15654904
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of hepatocyte growth factor on human cord blood CD34+ progenitor cells are the result of c-met receptor expression.
Goff JP; Shields DS; Petersen BE; Zajac VF; Michalopoulos GK; Greenberger JS
Stem Cells; 1996 Sep; 14(5):592-602. PubMed ID: 8888500
[TBL] [Abstract][Full Text] [Related]
20. [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation].
Klabusay M; Lysák D; Hrabcáková V; Navrátil M; Coupek P; Mayer J
Cas Lek Cesk; 2008; 147(6):319-24. PubMed ID: 18724529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
